Supply Chain

Allergan to sell off women's health, infectious disease units

After a strategic review, Allergan plans to sell its multibillion dollar women's health and infectious disease units, according to CNBC. By Alia Paavola - 5/30/18

A Hard Look at Soft Costs: 3 Hidden Ways to Save

Podcast Sneak Peak: Insights from a Health System Leader on what makes a Champion of Change in Supply Chains

Sponsored

In a recent interview, Joe Swartz, the administrative director of business transformation for Franciscan St. Francis Health, spoke about his organization’s ten years of effort in engaging every staff member in “kaizen,” or continuous improvement.

BioMarin wins FDA approval for rare genetic disease therapy: 3 things to know

The FDA approved BioMarin Pharmaceutical's therapy for adults with the rare inherited disorder phenylketonuria, the drugmaker announced May 24. By Mackenzie Bean - 5/29/18
FDA greenlights test to detect sepsis-causing bacteria in blood

The FDA granted market clearance to T2 Biosystems' test to detect sepsis-causing bacterial pathogens in blood samples, the company announced May 29. By Mackenzie Bean - 5/29/18
Medline donates $2.5k to Children's Burn Foundation

Medline raised $2,500 for the Children's Burn Foundation during the American Burn Association's annual meeting April 9-13 in Chicago. By Mackenzie Bean - 5/29/18
Supply chain tip of the day: 4 ways to promote continuous process improvement

Formalizing continuous process improvement offers hospitals numerous benefits, including an organizational commitment to excellence, reduced waste and increased operating efficiency. By Mackenzie Bean - 5/29/18

72% of pharma execs say Intermountain's drug venture is not a threat

While a majority of drug industry executives do not view Salt Lake City-based Intermountain Healthcare's newly formed generic drug company as a threat, most healthcare providers say they'd do business with the new venture, according to a report from Reaction Data. By Mackenzie Bean - 5/24/18
Red Cross offers blood donors $5 Amazon gift card to boost summer donations

The American Red Cross often sees a steep drop in blood donations starting around Memorial Day and continuing through the summer, due to vacations and school breaks. By Mackenzie Bean - 5/24/18
6 latest FDA approvals

Here are the six latest drugs or medical devices approved by the FDA since May 11. By Mackenzie Bean - 5/24/18
FDA OKs drug to control bleeding in chronic liver disease patients: 3 things to know

The FDA on May 21 approved Dova Pharmaceuticals' drug Doptelet to treat thrombocytopenia — a condition involving a low blood platelet count — in chronic liver disease patients set to undergo a medical or dental procedure. By Mackenzie Bean - 5/24/18

FDA approves AstraZeneca's potassium drug: 3 things to know

After two rejections, the FDA finally approved AstraZeneca's potassium drug Lokelma, the drugmaker announced May 18. By Mackenzie Bean - 5/23/18
How Mass General is dealing with the worst opioid shortage in years: 7 things to know

Boston-based Massachusetts General Hospital is one of many hospitals nationwide grappling with a severe shortage of intravenous opioids. By Mackenzie Bean - 5/23/18
FDA approves UTI detection device

The FDA has approved a detection device from BacterioScan, a St. Louis biotech startup, which can quickly diagnose patients with urinary tract infections, according to St. Louis Public Radio. By Alia Paavola - 5/22/18
90% of ER physicians had shortages of critical medicine in the last month: 5 notes

About 90 percent of emergency physicians have experienced shortages or absences of critical medications in their emergency departments in the last month, according to a recent poll conducted by the American College of Emergency Physicians. By Alia Paavola - 5/22/18
Supply chain salaries jumped 4% in 2017: 5 things to know

The salaries of supply chain professionals increased faster than overall U.S. wage gains in 2017, according to data from the Institute for Supply Management cited by The Wall Street Journal. By Mackenzie Bean - 5/21/18
FDA approves first biosimilar of 2018: 3 things to know

Pfizer earned FDA approval for its drug Retacrit — a biosimilar version of the anemia therapy Epogen/Procrit — May 15. By Mackenzie Bean - 5/18/18
Avoiding payer backlash? Amgen sets price of migraine drug at $6.9k

Amgen will charge $6,900 per year for its migraine prevention drug — a price 30 percent lower than Wall Street expectations — as the company attempts to dodge the payer backlash that has affected recent drug launches, according to STAT. By Alia Paavola - 5/18/18
FDA calls out drugmakers suspected of 'gaming' the system to delay generics

The FDA on May 16 released a list of drug companies that may be using "gaming tactics" to delay generic competition from hitting the market. By Mackenzie Bean - 5/17/18
Vermont first state to legalize drug importation from Canada

Vermont Republican Gov. Phil Scott signed a bill May 16 to permit the importation of cheaper prescription drugs from Canada, reports Politico. By Mackenzie Bean - 5/17/18

Page 7 of 50

«
Prev
2
3
4
5
6
7
8
9
10
11
Next
»

Allergan to sell off women's health, infectious disease units

A Hard Look at Soft Costs: 3 Hidden Ways to Save

FDA greenlights AI algorithm to detect wrist fractures

4 survey insights into how physicians think Amazon will alter prescribing practices

Podcast Sneak Peak: Insights from a Health System Leader on what makes a Champion of Change in Supply Chains

BioMarin wins FDA approval for rare genetic disease therapy: 3 things to know

FDA greenlights test to detect sepsis-causing bacteria in blood

Medline donates $2.5k to Children's Burn Foundation

Supply chain tip of the day: 4 ways to promote continuous process improvement

72% of pharma execs say Intermountain's drug venture is not a threat

Red Cross offers blood donors $5 Amazon gift card to boost summer donations

6 latest FDA approvals

FDA OKs drug to control bleeding in chronic liver disease patients: 3 things to know

FDA approves AstraZeneca's potassium drug: 3 things to know

How Mass General is dealing with the worst opioid shortage in years: 7 things to know

FDA approves UTI detection device

90% of ER physicians had shortages of critical medicine in the last month: 5 notes

Supply chain salaries jumped 4% in 2017: 5 things to know

FDA approves first biosimilar of 2018: 3 things to know

Avoiding payer backlash? Amgen sets price of migraine drug at $6.9k

FDA calls out drugmakers suspected of 'gaming' the system to delay generics

Vermont first state to legalize drug importation from Canada

Supply Chain Thought Leadership

Top 40 Articles from the Past 6 Months